Literature DB >> 1323361

Liver transplantation in tyrosinaemia type 1: the dilemma of timing the operation.

A Salt1, N D Barnes, K Rolles, R Y Calne, P T Clayton, J V Leonard.   

Abstract

Four children with tyrosinaemia type 1 received liver transplants. The metabolic disorder was corrected and all four had normal liver function on an unrestricted diet. Two children, transplanted at age five and seven years, proved to have occult hepatocellular carcinoma and both subsequently developed pulmonary metastases. One child was well 32 months after removal of a single pulmonary metastasis but the other child died with multiple metastases. The two younger children, transplanted at age 19 and 21 months, were well 28 and 44 months after operation, one after a second liver transplant. Our experience confirms the high risk of hepatocellular carcinoma in this disease and the potential value of early liver transplantation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323361     DOI: 10.1111/j.1651-2227.1992.tb12270.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  4 in total

1.  Liver transplantation in nine Spanish patients with tyrosinaemia type I.

Authors:  C Pérez-Cerdá; B Merinero; P Sanz; M Castro; J Gangoiti; M J García; M Díaz; E Medina; M Ugarte
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

2.  Liver transplantation in tyrosinaemia type I: the Groningen experience.

Authors:  F A Wijburg; W C Reitsma; M J Slooff; F J van Spronsen; H A Koetse; D J Reijngoud; G P Smit; R Berger; C M Bijleveld
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

3.  Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report.

Authors:  M Grompe; K Overturf; M al-Dhalimy; M Finegold
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

Review 4.  Liver Transplantation for Pediatric Hepatocellular Carcinoma: A Systematic Review.

Authors:  Christos D Kakos; Ioannis A Ziogas; Charikleia D Demiri; Stepan M Esagian; Konstantinos P Economopoulos; Dimitrios Moris; Georgios Tsoulfas; Sophoclis P Alexopoulos
Journal:  Cancers (Basel)       Date:  2022-03-02       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.